Home > Search Results: Buchanan, Daniel D.
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
2 p, 760.6 KB Author Correction : DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis / Tögel, Lars (La Trobe University School of Cancer Medicine) ; Nightingale, Rebecca (La Trobe University School of Cancer Medicine) ; Wu, Rui (Ludwig Institute for Cancer Research) ; Chüeh, Anderly C. (Ludwig Institute for Cancer Research) ; Al-Obaidi, Sheren (Ludwig Institute for Cancer Research) ; Luk, Ian (La Trobe University School of Cancer Medicine) ; Dávalos-Salas, Mercedes (La Trobe University School of Cancer Medicine) ; Chionh, Fiona (La Trobe University School of Cancer Medicine) ; Murone, Carmel (La Trobe University School of Cancer Medicine) ; Buchanan, Daniel D. (The University of Melbourne. Department of Pathology) ; Chatterton, Zac (The University of Melbourne. Department of Pathology) ; Sieber, Oliver M. (The Walter and Eliza Hall Institute of Medical Research. Systems Biology and Personalised Medicine Division) ; Arango, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tebbutt, Niall C. (La Trobe University School of Cancer Medicine) ; Williams, David (La Trobe University School of Cancer Medicine) ; Dhillon, Amardeep S. (La Trobe University School of Cancer Medicine) ; Mariadason, John M. (Ludwig Institute for Cancer Research)
2023 - 10.1038/s41598-023-29328-y
Scientific reports, Vol. 13 (february 2023)  
Detailed record - Creative Commons
2.
11 p, 6.9 MB DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis / Tögel, Lars (La Trobe University School of Cancer Medicine) ; Nightingale, Rebecca (La Trobe University School of Cancer Medicine) ; Wu, Rui (Ludwig Institute for Cancer Research) ; Chüeh, Anderly C. (Ludwig Institute for Cancer Research) ; Al-Obaidi, Sheren (Ludwig Institute for Cancer Research) ; Luk, Ian (La Trobe University School of Cancer Medicine) ; Dávalos-Salas, Mercedes (La Trobe University School of Cancer Medicine) ; Chionh, Fiona (La Trobe University School of Cancer Medicine) ; Murone, Carmel (La Trobe University School of Cancer Medicine) ; Buchanan, Daniel D. (The University of Melbourne) ; Chatterton, Zac (The University of Melbourne) ; Sieber, Oliver M. (The Walter and Eliza Hall Institute of Medical Research) ; Arango, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tebbutt, Niall C. (La Trobe University School of Cancer Medicine) ; Williams, David (La Trobe University School of Cancer Medicine) ; Dhillon, Amardeep S. (La Trobe University School of Cancer Medicine) ; Mariadason, John M. (Ludwig Institute for Cancer Research) ; Universitat Autònoma de Barcelona
The ERK signalling pathway regulates key cell fate decisions in the intestinal epithelium and is frequently dysregulated in colorectal cancers (CRCs). Variations in the dynamics of ERK activation can induce different biological outcomes and are regulated by multiple mechanisms, including activation of negative feedback loops involving transcriptional induction of dual-specificity phosphatases (DUSPs). [...]
2018 - 10.1038/s41598-018-20176-9
Scientific reports, Vol. 8 (january 2018)  
Detailed record - Creative Commons
3.
9 p, 435.9 KB Prediction of overall survival in stage II and III colon cancer beyond TNM system : a retrospective, pooled biomarker study / Dienstmann, Rodrigo. (Hospital Universitari Vall d'Hebron) ; Mason, M. J. (Computational Oncology, Sage Bionetworks, Seattle, USA) ; Sinicrope, F. A. (Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, USA) ; Phipps, A. I. (Fred Hutchinson Cancer Research Center, Seattle, USA) ; Tejpar, Sabine (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Nesbakken, A. (Oslo University Hospital (Oslo, Noruega)) ; Danielsen, S. A. (Oslo University Hospital (Oslo, Noruega)) ; Sveen, A. (Oslo University Hospital (Oslo, Noruega)) ; Buchanan, Daniel D (The University of Melbourne) ; Clendenning, M. (The University of Melbourne) ; Rosty, C. (The University of Melbourne) ; Bot, Brian M (Computational Oncology, Sage Bionetworks, Seattle, USA) ; Alberts, S. R. (Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, USA) ; Milburn Jessup, J. (National Cancer Institute (Rockville, Estats Units d'Amèrica)) ; Lothe, R. A. (Oslo University Hospital (Oslo, Noruega)) ; Delorenzi, Mauro (SIB Swiss Institute Bioinformatics, Lausanne, Switzerland) ; Newcomb, P. A. (Fred Hutchinson Cancer Research Center, Seattle, USA) ; Sargent, D. (Mayo Clinic, Rochester, USA) ; Guinney, J. (Computational Oncology, Sage Bionetworks, Seattle, USA) ; Universitat Autònoma de Barcelona
TNM staging alone does not accurately predict outcome in colon cancer (CC) patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the molecular markers microsatellite instability (MSI) and mutations in BRAF or KRAS improve prognostic estimation in multivariable models that include detailed clinicopathological annotation. [...]
2017 - 10.1093/annonc/mdx052
Annals of oncology, Vol. 28 (february 2017) , p. 1023-1031  
Detailed record - Creative Commons

See also: similar author names
1 Buchanan, Daniel D
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with